ISRCTN52352170已完成不适用
Angiotensin II Receptor Blockers in patients with systemic right ventricles
Academic Medical Center (AMC) (The Netherlands)0 个研究点目标入组 128 人开始时间: 2006年9月28日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 128
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •All adult patients with a systemic right ventricle due to a congenitally or surgically corrected transposition of the great arteries.
排除标准
- •1. Incapable of giving informed consen
- •2. Hypersensitivity to valsartan or any of its help substances
- •3. Known bilateral renal artery stenosis
- •4. Current symptomatic hypotension
- •5. Myocardial infarction, stroke or open-heart surgery in the previous four weeks
- •6. Previous heart transplant, or expected heart transplant within the next six months
- •7. Plasma creatinine level more than 250 µmol/L
- •8. Plasma potassium level more than 5.5 mmol/L
- •9. Pregnant or nursing women (a pregnancy test is offered to every female patient within the fertile age)
- •10. Desire to have children within the study period
- •11. Current treatment of hypertension with Angiotensin II receptor blockers or Angiotensin Converting Enzyme (ACE) inhibitors
研究者
相似试验
撤回
3 期
Angiotensin II receptor blockers in patients with systemic right ventricles.Transposition of the great arteriescongenitally corrected transposition of the great arteries10010394NL-OMON30035Academisch Medisch Centrum128
进行中（未招募）
1 期
Angiotensin II receptor blockers in patients with systemic right ventricle.Systemic right ventricle due to total transposition of the great arteries or congenitally corrected transposition of the great arteriesEUCTR2006-002262-19-NLovartis Pharma B.V.
尚未招募
不适用
Angiotensin II receptor blockers in patients with systemic right ventricles.Systemic right ventricle due to a congenitally or surgically corrected transposition of the great arteries.NL-OMON21444Academic Medical CentreMeibergdreef 91105 AZ AmsterdamThe Netherlands128
已完成
4 期
Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure LoweringHypertensionJPRN-UMIN000002531Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine30
已完成
不适用
The effects of angiotensin II receptor blockers (ARBs) on oxidative stress and atherosclerosis in patients with hypertension.Patients with hypertensionJPRN-UMIN000001300Second Department of Internal Medicine, Nagasaki University School of Medicine120